Clinical prognostic analysis of the core genes TREM2, TTC39A, GDF15, and ANXA2 demonstrated that their expression levels were significantly correlated with the survival outcomes of patients diagnosed with HCC. This evidence concerns the gene TTC39A and hepatocellular carcinoma.